Supernus and Indivior Announce All-Stock Merger

SentiSense · Published · Updated

Supernus and Indivior have agreed to merge in an all-stock deal, forming a CNS-focused drugmaker. The combined company will have a strengthened neuros...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis